Efficacy and safety of cyclophosphamide combined with mycophenolate mofetil for induction treatment of class IV lupus nephritis.

@article{Sun2015EfficacyAS,
  title={Efficacy and safety of cyclophosphamide combined with mycophenolate mofetil for induction treatment of class IV lupus nephritis.},
  author={Jian Sun and Hao Zhang and Ying Ji and Ming H. Gui and Bin Yi and Jianwen Wang and Juan Jiang},
  journal={International journal of clinical and experimental medicine},
  year={2015},
  volume={8 11},
  pages={21572-8}
}
The present study aimed to evaluate the efficacy and safety of combination of cyclophosphamide (CTX) and mycophenolate mofetil (MMF) as induction treatment in Chinese patients with class IV lupus nephritis (LN). 82 patients were randomly divided into control (CTX, n=40) and test (CTX+MMF, n=42) groups, and they received monthly dose of 0.75 g/m(2) of body surface area of CTX and monthly dose of 0.4 g/m(2) CTX plus 1.0 g/d MMF, respectively. Patients were followed up for six months after… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 26 references

A comparison of the quality of life of patients with systemic lupus CTX combined with MMF for class IV lupus nephritis

TV Vu, A. Escalante
Int J Clin Exp Med • 2015

Significance of histological crescent CTX combined with MMF for class IV lupus nephritis

S Chen, Z Tang, +4 authors Z. Liu
Int J Clin Exp Med • 2015
View 1 Excerpt

Treatment of lupus nephritis: practical issues in Asian countries.

International journal of rheumatic diseases • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…